These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 15180953

  • 1. RAGE- and TGF-beta receptor-mediated signals converge on STAT5 and p21waf to control cell-cycle progression of mesangial cells: a possible role in the development and progression of diabetic nephropathy.
    Brizzi MF, Dentelli P, Rosso A, Calvi C, Gambino R, Cassader M, Salvidio G, Deferrari G, Camussi G, Pegoraro L, Pagano G, Cavallo-Perin P.
    FASEB J; 2004 Aug; 18(11):1249-51. PubMed ID: 15180953
    [Abstract] [Full Text] [Related]

  • 2. Angiopoietin 2 induces cell cycle arrest in endothelial cells: a possible mechanism involved in advanced plaque neovascularization.
    Calvi C, Dentelli P, Pagano M, Rosso A, Pegoraro M, Giunti S, Garbarino G, Camussi G, Pegoraro L, Brizzi MF.
    Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):511-8. PubMed ID: 14726409
    [Abstract] [Full Text] [Related]

  • 3. Advanced glycation end product-induced proliferation in NRK-49F cells is dependent on the JAK2/STAT5 pathway and cyclin D1.
    Guh JY, Huang JS, Chen HC, Hung WC, Lai YH, Chuang LY.
    Am J Kidney Dis; 2001 Nov; 38(5):1096-104. PubMed ID: 11684565
    [Abstract] [Full Text] [Related]

  • 4. Advanced glycosylation end products stimulate collagen mRNA synthesis in mesangial cells mediated by protein kinase C and transforming growth factor-beta.
    Kim YS, Kim BC, Song CY, Hong HK, Moon KC, Lee HS.
    J Lab Clin Med; 2001 Jul; 138(1):59-68. PubMed ID: 11433229
    [Abstract] [Full Text] [Related]

  • 5. Advanced glycation end products activate Smad signaling via TGF-beta-dependent and independent mechanisms: implications for diabetic renal and vascular disease.
    Li JH, Huang XR, Zhu HJ, Oldfield M, Cooper M, Truong LD, Johnson RJ, Lan HY.
    FASEB J; 2004 Jan; 18(1):176-8. PubMed ID: 12709399
    [Abstract] [Full Text] [Related]

  • 6. Beta-hydroxybutyrate-induced growth inhibition and collagen production in HK-2 cells are dependent on TGF-beta and Smad3.
    Guh JY, Chuang TD, Chen HC, Hung WC, Lai YH, Shin SJ, Chuang LY.
    Kidney Int; 2003 Dec; 64(6):2041-51. PubMed ID: 14633126
    [Abstract] [Full Text] [Related]

  • 7. Smad-dependent stimulation of type I collagen gene expression in human skin fibroblasts by TGF-beta involves functional cooperation with p300/CBP transcriptional coactivators.
    Ghosh AK, Yuan W, Mori Y, Varga J.
    Oncogene; 2000 Jul 20; 19(31):3546-55. PubMed ID: 10918613
    [Abstract] [Full Text] [Related]

  • 8. Overexpression of transforming growth factor (TGF) beta1 type II receptor restores TGF-beta1 sensitivity and signaling in human prostate cancer cells.
    Guo Y, Kyprianou N.
    Cell Growth Differ; 1998 Feb 20; 9(2):185-93. PubMed ID: 9486855
    [Abstract] [Full Text] [Related]

  • 9. SPARC regulates cell cycle progression in mesangial cells via its inhibition of IGF-dependent signaling.
    Francki A, Motamed K, McClure TD, Kaya M, Murri C, Blake DJ, Carbon JG, Sage EH.
    J Cell Biochem; 2003 Mar 01; 88(4):802-11. PubMed ID: 12577314
    [Abstract] [Full Text] [Related]

  • 10. Glycated albumin activates PAI-1 transcription through Smad DNA binding sites in mesangial cells.
    Lee HS, Moon KC, Song CY, Kim BC, Wang S, Hong HK.
    Am J Physiol Renal Physiol; 2004 Oct 01; 287(4):F665-72. PubMed ID: 15198928
    [Abstract] [Full Text] [Related]

  • 11. AGEs activate mesangial TGF-beta-Smad signaling via an angiotensin II type I receptor interaction.
    Fukami K, Ueda S, Yamagishi S, Kato S, Inagaki Y, Takeuchi M, Motomiya Y, Bucala R, Iida S, Tamaki K, Imaizumi T, Cooper ME, Okuda S.
    Kidney Int; 2004 Dec 01; 66(6):2137-47. PubMed ID: 15569303
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Suppressions of chronic glomerular injuries and TGF-beta 1 production by HGF in attenuation of murine diabetic nephropathy.
    Mizuno S, Nakamura T.
    Am J Physiol Renal Physiol; 2004 Jan 01; 286(1):F134-43. PubMed ID: 14519594
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Transforming growth factor-beta-induced inhibition of myogenesis is mediated through Smad pathway and is modulated by microtubule dynamic stability.
    Zhu S, Goldschmidt-Clermont PJ, Dong C.
    Circ Res; 2004 Mar 19; 94(5):617-25. PubMed ID: 14739161
    [Abstract] [Full Text] [Related]

  • 16. Smad expression in human atherosclerotic lesions: evidence for impaired TGF-beta/Smad signaling in smooth muscle cells of fibrofatty lesions.
    Kalinina N, Agrotis A, Antropova Y, Ilyinskaya O, Smirnov V, Tararak E, Bobik A.
    Arterioscler Thromb Vasc Biol; 2004 Aug 19; 24(8):1391-6. PubMed ID: 15166010
    [Abstract] [Full Text] [Related]

  • 17. RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy.
    Wendt TM, Tanji N, Guo J, Kislinger TR, Qu W, Lu Y, Bucciarelli LG, Rong LL, Moser B, Markowitz GS, Stein G, Bierhaus A, Liliensiek B, Arnold B, Nawroth PP, Stern DM, D'Agati VD, Schmidt AM.
    Am J Pathol; 2003 Apr 19; 162(4):1123-37. PubMed ID: 12651605
    [Abstract] [Full Text] [Related]

  • 18. Transforming growth factor-beta (TGF-beta) stimulates the expression of beta1 integrins and adhesion by rat mesangial cells.
    Kagami S, Kuhara T, Yasutomo K, Okada K, Löster K, Reutter W, Kuroda Y.
    Exp Cell Res; 1996 Nov 25; 229(1):1-6. PubMed ID: 8940242
    [Abstract] [Full Text] [Related]

  • 19. SPARC regulates TGF-beta1-dependent signaling in primary glomerular mesangial cells.
    Francki A, McClure TD, Brekken RA, Motamed K, Murri C, Wang T, Sage EH.
    J Cell Biochem; 2004 Apr 01; 91(5):915-25. PubMed ID: 15034927
    [Abstract] [Full Text] [Related]

  • 20. Purple corn anthocyanins dampened high-glucose-induced mesangial fibrosis and inflammation: possible renoprotective role in diabetic nephropathy.
    Li J, Lim SS, Lee JY, Kim JK, Kang SW, Kim JL, Kang YH.
    J Nutr Biochem; 2012 Apr 01; 23(4):320-31. PubMed ID: 21543205
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.